Table 5.

The Relation of Pretreatment Abstinence in months to HCV Treatment Failure, Adjusted for Host and Viral Risk Factors. Multiple Logistic Regression, Adjusted Odds Ratios, 95% Confidence Intervals (CI), and Significance Levels (N = 200).

Risk Factors	Odds Ratios (95% CI)	ρ Values
Hispanic and/or non-White	2.31 (1.02 – 5.23)	.044
Pretreatment Viral Load	1.98 (1.02 – 3.86)	.045
HCV Genotype 1/4/6	4.14 (2.07 – 8.27)	<.001
Advanced Fibrosis	1.81 (.910 – 3.60)	.091
Treatment Discontinuation	7.29 (2.50 – 21.3)	<.001
Pretreatment Abstinence (Mo.)	.998 (.993 – 1.004)	.502